Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in nonpregnant women
HIGHLIGHTS who: Respiratory syncytial virus (RSV) and collaborators from the Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, […]